Research output: Contribution to journal › Article › peer-review
Antibodies to highly pathogenic A/H5Nx (Clade 2.3.4.4) influenza viruses in the sera of vietnamese residents. / Ilyicheva, Tatyana; Marchenko, Vasily; Pyankova, Olga et al.
In: Pathogens, Vol. 10, No. 4, 394, 04.2021.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Antibodies to highly pathogenic A/H5Nx (Clade 2.3.4.4) influenza viruses in the sera of vietnamese residents
AU - Ilyicheva, Tatyana
AU - Marchenko, Vasily
AU - Pyankova, Olga
AU - Moiseeva, Anastasia
AU - Nhai, Tran Thi
AU - Lan Anh, Bui Thi
AU - Sau, Trinh Khac
AU - Kuznetsov, Andrey
AU - Ryzhikov, Alexander
AU - Maksyutov, Rinat
N1 - Publisher Copyright: © 2021 by the authors. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/4
Y1 - 2021/4
N2 - To cause a pandemic, an influenza virus has to overcome two main barriers. First, the virus has to be antigenically new to humans. Second, the virus has to be directly transmitted from humans to humans. Thus, if the avian influenza virus is able to pass the second barrier, it could cause a pandemic, since there is no immunity to avian influenza in the human population. To determine whether the adaptation process is ongoing, analyses of human sera could be conducted in populations inhabiting regions where pandemic virus variant emergence is highly possible. This study aimed to analyze the sera of Vietnamese residents using hemagglutinin inhibition reaction (HI) and microneutralization (MN) with A/H5Nx (clade 2.3.4.4) influenza viruses isolated in Vietnam and the Russian Federation in 2017-2018. In this study, we used sera from 295 residents of the Socialist Republic of Vietnam collected from three groups: 52 samples were collected from households in Nam Dinh province, where poultry deaths have been reported (2017); 96 (2017) and 147 (2018) samples were collected from patients with somatic but not infectious diseases in Hanoi. In all, 65 serum samples were positive for HI, at least to one H5 virus used in the study. In MN, 47 serum samples neutralizing one or two viruses at dilutions of 1/40 or higher were identified. We postulate that the rapidly evolving A/H5Nx (clade 2.3.4.4) influenza virus is possibly gradually adapting to the human host, insofar as healthy individuals have antibodies to a wide spectrum of variants of that subtype.
AB - To cause a pandemic, an influenza virus has to overcome two main barriers. First, the virus has to be antigenically new to humans. Second, the virus has to be directly transmitted from humans to humans. Thus, if the avian influenza virus is able to pass the second barrier, it could cause a pandemic, since there is no immunity to avian influenza in the human population. To determine whether the adaptation process is ongoing, analyses of human sera could be conducted in populations inhabiting regions where pandemic virus variant emergence is highly possible. This study aimed to analyze the sera of Vietnamese residents using hemagglutinin inhibition reaction (HI) and microneutralization (MN) with A/H5Nx (clade 2.3.4.4) influenza viruses isolated in Vietnam and the Russian Federation in 2017-2018. In this study, we used sera from 295 residents of the Socialist Republic of Vietnam collected from three groups: 52 samples were collected from households in Nam Dinh province, where poultry deaths have been reported (2017); 96 (2017) and 147 (2018) samples were collected from patients with somatic but not infectious diseases in Hanoi. In all, 65 serum samples were positive for HI, at least to one H5 virus used in the study. In MN, 47 serum samples neutralizing one or two viruses at dilutions of 1/40 or higher were identified. We postulate that the rapidly evolving A/H5Nx (clade 2.3.4.4) influenza virus is possibly gradually adapting to the human host, insofar as healthy individuals have antibodies to a wide spectrum of variants of that subtype.
KW - H5N6 (clade 2.3.4.4)
KW - Highly pathogenic avian influenza virus
KW - Human sera
UR - http://www.scopus.com/inward/record.url?scp=85103581971&partnerID=8YFLogxK
U2 - 10.3390/pathogens10040394
DO - 10.3390/pathogens10040394
M3 - Article
C2 - 33806156
AN - SCOPUS:85103581971
VL - 10
JO - Pathogens
JF - Pathogens
SN - 2076-0817
IS - 4
M1 - 394
ER -
ID: 28317049